Clinical characteristics of the digestive system in COVID-19 cases
DOI:
https://doi.org/10.24265/horizmed.2022.v22n3.13Keywords:
Digestive System, Diarrhea, Coronavirus InfectionsAbstract
At the beginning of the COVID-19 pandemic, digestive problems were not evident among patients suffering from the initial disease in Wuhan, China: only 2.6 % had diarrhea and 2 % chronic liver disease.
The virus enters the cells through the receptors of the angiotensin-converting enzyme 2 (ACE2). Recent studies have shown that the ACE2 receptor (which mainly regulates the intestinal flora) is essential for COVID-19-infected cells and is highly expressed not only in the AT2 cells but also in the enterocytes of the ileum and colon. These results confirmed that the gastrointestinal tract may be a potential route for COVID-19 infection.
A bibliographic search, which consisted of a review of biomedical literature from MEDLINE, life science journals and online sources on gastrointestinal manifestations during COVID-19 infection, was carried out in PubMed.
It is concluded that gastrointestinal manifestations occur during COVID-19 infection, so it is important to know them for providing a timely treatment.
Downloads
References
Kane-Sunanda V. Coronavirus disease 2019 (COVID-19): issues related to gastrointestinal disease in adults [Internet]. UpToDate. 2020. Disponible en: https://www.uptodate.com/contents/covid-19-issues-related-to-gastrointestinal-disease-in-adults
Li Y-D, Chi W-Y, Su J-H, Ferrall L, Hung C-F, Wu T-C. Coronavirus vaccine development: from SARS and MERS to COVID-19. J Biomed Sci. 2020; 27(1): 104.
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11): 1061-9.
Ruiz-Manriquez J, León-Lara X, Campos-Murguía A, Solis-Ortega AA, Pérez-González B, Uscanga LF, et al. Conocimiento sobre la infección por SARS-CoV-2 de gastroenterólogos y endoscopistas de Latino América. Rev Gastroenterol Mex. 2020; 85(3): 288-94.
Shinu P, Morsy MA, Deb PK, Nair AB, Goyal M, Shah J, et al. SARS CoV-2 organotropism associated pathogenic relationship of gut-brain axis and illness. Front Mol Biosci. 2020; 7: 606779.
Blanco-Colino R, Vilallonga R, Martín R, Petrola C, Armengol M. Sospecha de abdomen agudo como manifestación extrapulmonar de infección por Covid-19. Cir Esp. 2020; 98(5): 295-6.
Cha MH, Regueiro M, Sandhu DS. Gastrointestinal and hepatic manifestations of COVID-19: a comprehensive review. World J Gastroenterol. 2020; 26(19): 2323-32.
Lei H-Y, Ding Y-H, Nie K, Dong Y-M, Xu J-H, Yang M-L, et al. Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver. Biomed Pharmacother. 2021; 133: 111064.
Zhou Z, Zhao N, Shu Y, Han S, Chen B, Shu X. Effect of gastrointestinal symptoms in patients with COVID-19. Gastroenterology. 2020; 158(8): 2294-7.
Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, et al. AGA Institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 2020; 159(1): 320-34.e27.
Sebastián Domingo JJ. COVID-19 y aparato digestivo. Med Clín. 2020; 155(2): 68-9.
Ferm S, Fisher C, Pakala T, Tong M, Shah D, Schwarzbaum D, et al. Analysis of gastrointestinal and hepatic manifestations of SARS-CoV-2 infection in 892 patients in Queens, NY. Clin Gastroenterol Hepatol. 2020; 18(10): 2378-9.e1.
Shinu P, Morsy MA, Deb PK, Nair AB, Goyal M, Shah J, et al. SARS CoV-2 organotropism associated pathogenic relationship of gut-brain axis and illness. Front Mol Biosci. 2020; 7: 606779.
IETSI-ESSALUD.RB31_FISIOPATOLOGÍA_GASTRO.pdf [Internet]. Disponible en: http://www.essalud.gob.pe/ietsi/pdfs/covid_19/RB31_FISIOPATOLOGÍA_GASTRO.pdf
Perisetti A, Gajendran M, Goyal H. Putative mechanisms of diarrhea in COVID-19. Clin Gastroenterol Hepatol. 2020; 18(13): 3054-5.
Hariyanto TI, Prasetya IB, Kurniawan A. Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection. Dig Liver Dis. 2020; 52(12): 1410-2.
Harrison L. Inhibidores de la bomba de protones vinculados al riesgo de COVID-19 [Internet]. 2020. Disponible en: https://espanol.medscape.com/verarticulo/5905675
Price E, Treacher DF. Reduced gastric acidity, proton pump inhibitors and increased severity of COVID-19 infections. Critical Care. 2021; 73(25).
Da Silva FAF, de Brito BB, Santos MLC, Marques HS, da Silva Júnior RT, de Carvalho LS, et al. COVID-19 gastrointestinal manifestations: a systematic review. Rev Soc Bras Med Trop. 2020; 53: e20200714.
Lee I-C, Huo T-I, Huang Y-H. Gastrointestinal and liver manifestations in patients with COVID-19. J Chin Med Assoc. 2020; 83(6): 521-3.
Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020; 51(9): 843-51.
Gil JMG, González JLG, Curbelo ONM. Abdomen agudo durante la pandemia COVID-19. Rev Cubana Cir. 2020; 59(2): e957.
Schmulson M, Dávalos MF, Berumen J. Alerta: los síntomas gastrointestinales podrían ser una manifestación de la COVID-19. Rev Gastroenterol Méx. 2020; 85(3): 282-7.
Quintero-Barzola ID, Galindo-Velásquez HA, Rodríguez-Blanco JD, Quintana-Pájaro LDJ, Ramos-Villegas Y, Jesús-Yepes ID. Evidencia de alteraciones gastrointestinales en COVID-19: manifestaciones y teorías en fisiopatología. Rev Colomb Gastroenterol. 2020.
Redd WD, Zhou JC, Hathorn KE, McCarty TR, Bazarbashi AN, Thompson CC, et al. Prevalence and characteristics of gastrointestinal symptoms in patients with severe acute respiratory syndrome coronavirus 2 infection in the United States: a multicenter cohort study. Gastroenterology. 2020; 159(2): 765-7.e2.
Domingo JJS. COVID-19 y aparato digestivo. Med Clín. 2020; 155(2): 68-9.
D’Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol. 2020; 18(8): 1663-72.
Shehab M, Alrashed F, Shuaibi S, Alajmi D, Barkun A. Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis. BMJ Open Gastroenterol. 2021; 8(1): e000571.
Villanueva CM, Faundez HR, Godoy M. Gastrointestinal and hepatic manifestations of COVID-19 in children. Rev Chil Pediatr. 2020; 91(4): 623-30.
Velarde-Ruiz Velasco JA, García-Jiménez ES, Remes-Troche JM. Hepatic manifestations and impact of COVID-19 on the cirrhotic patient. Rev Gastroenterol Mex (Engl Ed). 2020; 85(3): 303-11.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
